COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 2808: Articles 28071-28080  | Next

Mental Health Impact of COVID-19: A global study of risk and resilience factors
Plomecka, M. B., Gobbi, S., Neckels, R., Radzinski, P., Skorko, B., Lazerri, S., Almazidou, K., Dedic, A., Bakalovic, A., Hrustic, L., Ashraf, Z., Es haghi, S., Rodriguez-Pino, L., Waller, V., Jabeen, H., Alp, A. B., Behnam, M. A., Shibli, D., Baranczuk Turska, Z., Haq, Z., Qureshi, S. U., Strutt, A. M., Jawaid, A.
10.1101/2020.05.05.20092023 — Posted: 2020-05-09 Discussion: Onsite
Knowledge, Attitude and Practice Towards Novel Corona Virus among Bangladeshi People: Implications for mitigation measures
Paul, A., Sikdar, D., Hossain, M. M., Amin, M. R., Deeba, F., Mahanta, J., Jabed, M. A., Islam, M. M., Noon, S. J., Nath, T. K.
10.1101/2020.05.05.20091181 — Posted: 2020-05-09
A sub-national analysis of the rate of transmission of COVID-19 in Italy
Vollmer, M. A., Mishra, S., Unwin, H. J., Gandy, A., Mellan, T. A., Bradley, V., Zhu, H., Coupland, H., Hawryluk, I., Hutchinson, M., Ratmann, O., Monod, M., Walker, P., Whittaker, C., Cattarino, L., Ciavarella, C., Cilloni, L., Ainslie, K., Baguelin, M., Bhatia, S., Boonyasiri, A., Brazeau, N., Charles, G., Cooper, L. V., Cucunuba, Z., Cuomo-Dannenburg, G., Dighe, A., Djaafara, B., Eaton, J., van Elsland, S. L., FitzJohn, R., Fraser, K., Gaythorpe, K., Green, W., Hayes, S., Imai, N., Jeffrey, B., Knock, E., Laydon, D., Lees, J., Mangal, T., Mousa, A., Nedjati-Gilani, G., Nouvellet, P., Olivera, D., Parag, K. V., Pickles, M., Thompson, H. A., Verity, R., Walters, C., Wang, H., Wang, Y., Watson, O. J., Whittles, L., Xi, X., Ghani, A. A., Riley, S., Okell, L. C., Donnelly, C. A., Ferguson, N. M., Dorigatti, I., Flaxman, S., Bhatt, S.
10.1101/2020.05.05.20089359 — Posted: 2020-05-09
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
Martinez-Vizcaino, V., Mesas, A. E., Cavero-Redondo, I., Saz-Lara, A., Sequi-Dominguez, I., Pascual-Morena, C., Alvarez-Bueno, C.
10.1101/2020.05.05.20091785 — Posted: 2020-05-09
Predicting Covid-19's spread in Africa: rural and relatively young population may limit the spread and severity
Diop, B. Z., Ngom, M., Pougue Biyong, C., Pougue Biyong, J. N.
10.1101/2020.05.03.20089532 — Posted: 2020-05-08
Spatial Network based model forecasting transmission and control of COVID-19
Gupta, A. K., Sharma, N., Verma, A. K.
10.1101/2020.05.06.20092858 — Posted: 2020-05-08
Epidemiological Transition of Covid-19 in India from Higher to Lower HDI States and Territories: Implications for Prevention and Control
Gupta, R., Dhamija, R. K., Gaur, K.
10.1101/2020.05.05.20092593 — Posted: 2020-05-08
Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data
Prats-Uribe, A., Paredes, R., PRIETO-ALHAMBRA, D.
10.1101/2020.05.06.20092676 — Posted: 2020-05-08
PREEXISTING COMORBIDITIES PREDICTING SEVERE COVID-19 IN OLDER ADULTS IN THE UK BIOBANK COMMUNITY COHORT
Atkins, J. L., Masoli, J. A., Delgado, J., Pilling, L. C., Kuo, C.-L. C., Kuchel, G., Melzer, D.
10.1101/2020.05.06.20092700 — Posted: 2020-05-08 Discussion: Onsite
Weather Conditions and COVID-19 Transmission: Estimates and Projections
Xu, R., Rahmandad, H., Gupta, M., DiGennaro, C., Ghaffarzadegan, N., Jalali, M. S.
10.1101/2020.05.05.20092627 — Posted: 2020-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).